Publicaciones (25) Publicaciones de ANDREA ACEBES HUERTA

2024

  1. Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions

    Acta Biomaterialia, Vol. 177, pp. 132-147

2023

  1. Proteomics-wise, how similar are mouse and human platelets?

    Platelets, Vol. 34, Núm. 1, pp. 2220415

2022

  1. Clinical Response After Treatment of Knee Osteoarthritis With a Standardized, Closed-System, Low-Cost Platelet-Rich Plasma Product: 1-Year Outcomes

    Orthopaedic Journal of Sports Medicine, Vol. 10, Núm. 3

  2. Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation

    Transfusion and Apheresis Science, Vol. 61, Núm. 2

2021

  1. Clinical management of hypertension, inflammation and thrombosis in hospitalized covid‐19 patients: Impact on survival and concerns

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-16

  2. Comparison of the PU.1 transcriptional regulome and interactome in human and mouse inflammatory dendritic cells

    Journal of Leukocyte Biology, Vol. 110, Núm. 4, pp. 735-751

  3. Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

    Journal of visualized experiments : JoVE

  4. Xeno-free approach for the expansion of human adipose derived mesenchymal stem cells for ocular therapies

    Experimental Eye Research, Vol. 202

2020

  1. In vitro platelet production for transfusion purposes: Where are we now?

    Transfusion and Apheresis Science, Vol. 59, Núm. 4

  2. On the quest for in vitro platelet production by re-tailoring the concepts of megakaryocyte differentiation

    Medicina (Lithuania), Vol. 56, Núm. 12, pp. 1-18

  3. Optimising platelet secretomes to deliver robust tissue-specific regeneration

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 14, Núm. 1, pp. 82-98

  4. Platelet-derived bio-products: Classification update, applications, concerns and new perspectives

    Transfusion and Apheresis Science, Vol. 59, Núm. 1

2019

  1. Implementation of a closed platelet-rich-plasma preparation method using the local blood bank infrastructure at the Principality of Asturias (Spain): Back to basic methodology and a demographics perspective after 1 year

    Transfusion and Apheresis Science, Vol. 58, Núm. 5, pp. 701-704

2016

  1. Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

    Journal of Biomedical Informatics, Vol. 60, pp. 342-351

  2. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

    OncoImmunology, Vol. 5, Núm. 2

2015

  1. NKG2D signaling in cancer immunosurveillance

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1741-1750

  2. Pleiotropic anti-angiogenic and anti-oncogenic activities of the novel mithralog demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (EC-8042)

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

    BioMed Research International, Vol. 2014

  3. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology